9:15 – 9:45

Findings of the ACP Foundation White Paper on Drug Labeling


Michael Wolf, Ph.D., M.P.H.


Assistant Professor of Preventive Medicine

Feinberg School of Medicine, Northwestern University

9:45 – 10:00

Discussion of Morning Presentations

10:00 – 10:30

Simplification of Drug Dosing Times: Can We Confuse Patients Less? A Proposal for Standardization


Alastair J. J. Wood, M.D., F.A.C.P.


Managing Director

Symphony Capital LLC

10:30 – 11:30

Panel I: Federal Agency Reaction to Prescription Use Instruction Standardization


Cindy Brach, M.P.P.


Senior Health Policy Researcher

Agency for Healthcare Research and Quality


Nancy Ostrove, Ph.D.


Senior Advisor for Risk Communication, Office of Planning, Office of the Commissioner, Food and Drug Administration


Virginia Torrise, Pharm.D.


Deputy Chief Consultant for Pharmacy Benefits Management

Department of Veterans Affairs

11:30 – 12:45

Panel II: Pharmacy Reaction to Prescription Use Instruction Standardization


Alan Goldhammer, Ph.D.


Deputy Vice President, Regulatory Affairs



Darren K. Townzen, R.Ph., M.B.A.


Director of Pharmacy Systems



Gerald McEvoy, Pharm.D.


Assistant Vice President of Drug Information

American Society of Health-System Pharmacists


William Ellis, R.Ph., M.S.


Chief Executive Officer

American Pharmacists Association Foundation

12:45 – 1:30

Lunch Break

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement